Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment

Our findings demonstrate that a large percentage of patients with hypertriglyceridemia or impaired glucose tolerance, treated with lipid lowering agents, reach the LDL-cholesterol but not the apo B treatment targets.